138 related articles for article (PubMed ID: 31375898)
1. Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report.
Tsuchida K; Mitsuma W; Sato Y; Ozaki K; Soda S; Hatada K; Tanaka K; Hosaka Y; Imai S; Takahashi K; Matsubara T; Oda H
Acta Diabetol; 2020 Feb; 57(2):173-182. PubMed ID: 31375898
[TBL] [Abstract][Full Text] [Related]
2. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study.
George A; Bhatia RT; Buchanan GL; Whiteside A; Moisey RS; Beer SF; Chattopadhyay S; Sathyapalan T; John J
PLoS One; 2015; 10(11):e0142045. PubMed ID: 26571120
[TBL] [Abstract][Full Text] [Related]
3. Higher blood pressure predicts diabetes and enhances long-term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study.
Li X; Wang J; Shen X; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G
J Diabetes; 2019 Jul; 11(7):593-598. PubMed ID: 30556339
[TBL] [Abstract][Full Text] [Related]
4. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Makino A; Nakamura T; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
Atherosclerosis; 2010 Dec; 213(2):573-8. PubMed ID: 20934703
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Ferrannini G; De Bacquer D; Vynckier P; De Backer G; Gyberg V; Kotseva K; Mellbin L; Norhammar A; Tuomilehto J; Wood D; Rydén L;
Cardiovasc Diabetol; 2021 Feb; 20(1):38. PubMed ID: 33573665
[TBL] [Abstract][Full Text] [Related]
6. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
[TBL] [Abstract][Full Text] [Related]
7. Impaired glucose tolerance predicts all-cause mortality among older men at high risk for cardiovascular disease in China.
Fang F; Wang N; Yan S; Wang L; Lu Y; Li J; Li H; Pham G; Li C; Leng SX; Tian H
Prim Care Diabetes; 2019 Dec; 13(6):495-504. PubMed ID: 30862424
[TBL] [Abstract][Full Text] [Related]
8. [Abnormal glucose tolerance and long-term prognosis in patients with acute myocardial infarction].
David LA; Grosu AA
Kardiologiia; 2013; 53(9):15-20. PubMed ID: 24090381
[TBL] [Abstract][Full Text] [Related]
9. Impaired glucose tolerance is a risk factor for stroke in a Japanese sample--the Funagata study.
Oizumi T; Daimon M; Jimbu Y; Wada K; Kameda W; Susa S; Yamaguchi H; Ohnuma H; Tominaga M; Kato T
Metabolism; 2008 Mar; 57(3):333-8. PubMed ID: 18249204
[TBL] [Abstract][Full Text] [Related]
10. Preoperative oral glucose tolerance testing in vascular surgery patients: long-term cardiovascular outcome.
van Kuijk JP; Dunkelgrun M; Schreiner F; Flu WJ; Galal W; van Domburg RT; Hoeks SE; van Gestel YR; Bax JJ; Poldermans D
Am Heart J; 2009 May; 157(5):919-25. PubMed ID: 19376322
[TBL] [Abstract][Full Text] [Related]
11. Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial.
Wamil M; McMurray JJV; Scott CAB; Coleman RL; Sun Y; Standl E; Rydén L; Holman RR
Diabetes Res Clin Pract; 2020 Dec; 170():108488. PubMed ID: 33035598
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities.
Kowalczyk J; Mazurek M; Zielinska T; Lenarczyk R; Sedkowska A; Swiatkowski A; Sredniawa B; Mencel G; Francuz P; Kalarus Z
Eur J Prev Cardiol; 2015 Jun; 22(6):798-806. PubMed ID: 24618476
[TBL] [Abstract][Full Text] [Related]
13. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
[TBL] [Abstract][Full Text] [Related]
14. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
[TBL] [Abstract][Full Text] [Related]
15. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Unwin N; Shaw J; Zimmet P; Alberti KG
Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
[TBL] [Abstract][Full Text] [Related]
16. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
17. Role of impaired glucose tolerance in patients with acute myocardial infarction in relation to sex.
Sędkowska A; Kowalczyk J; Woźniak A; Kurek T; Zielińska T; Strojek K; Gumprecht J; Kalarus Z
Pol Arch Med Wewn; 2014; 124(9):467-73. PubMed ID: 24995511
[TBL] [Abstract][Full Text] [Related]
18. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
19. Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention.
Kuramitsu S; Yokoi H; Domei T; Nomura A; Watanabe H; Yamaji K; Soga Y; Arita T; Kondo K; Shirai S; Ando K; Sakai K; Iwabuchi M; Nosaka H; Nobuyoshi M
Cardiovasc Diabetol; 2013 May; 12():74. PubMed ID: 23651930
[TBL] [Abstract][Full Text] [Related]
20. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose.
Li CH; Wu JS; Yang YC; Shih CC; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Apr; 97(4):E658-62. PubMed ID: 22337914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
